OUR EXPERTISE
- In vitro assay for identifying anti-inflammatory potential using cell lines or primary culture cells to induce phenotypes associated with various inflammatory diseases (atopic dermatitis, inflammatory bowel diseases, psoriasis, asthma)
- Use of primary human cells (peripheral blood mononuclear cells (PBMCs), monocytes, dendritic cells, keratinocytes, fibroblasts, or reconstituted human skin)
- Animal models for the study of inflammatory bowel diseases (DSS-induced ulcerative colitis, TNBS-induced ulcerative colitis)
- Animal models for the study of cutaneous inflammation (oxazolone-induced atopic dermatitis, MC903-induced atopic dermatitis, imiquimod-induced psoriasis)
- Animal model for the study of joint inflammation (MIA-induced osteoarthritis)
- Animal models for the study of respiratory diseases (LPS-induced acute respiratory distress, dust mite-induced allergic asthma)
- Cytokine and chemokine expression (ELISA, multiplex, IF, cytometry)
- Gene expression by RT-qPCR (cytokines, chemokines, junctional proteins, etc.)
- Cell population analysis (cytometry, IF)
- Histological analyses
- Development of customized tests or models for your specific needs

A team of experts
The inflammatory response studied
INFLAMMATION
TransBIOTech utilizes proven in vitro and in vivo models to conduct proof-of-concept studies and generate data for identifying the anti-inflammatory potential of your compounds.
CONTACT US
Your R&D projects require distinctive expertise that cannot be improvised. TransBIOTech provides you with complete and proven know-how with +150 projects per year, with +50 clients and partners.
Inflammation
Your TEAM in
Inflammation

View Bio
Julie de Grandmont
Laboratory Technician - Analytical Chemistry, Certificate in Biotechnologies


















